Inhibrx Biosciences Logo

Inhibrx Biosciences

🇺🇸
INBX
US45720N1037

Inhibrx Biosciences is a US-based biopharmaceutical company specializing in the development of novel protein therapeutics. Through innovative platform technologies, Inhibrx focuses on the treatment of complex cancers and rare disease indications, advancing transformative therapies for patients in need.

Next Quarterly Earnings

Friday, November 13, 2026
CW 46
After-Hours
In 78 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 16, 2026

Stock Price

Frequently asked questions

When will Inhibrx Biosciences report its next quarterly earnings?

Inhibrx Biosciences is scheduled to report its next quarterly earnings on 11/13/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Inhibrx Biosciences last report quarterly earnings?

Inhibrx Biosciences last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -2.34 USD.

How often has Inhibrx Biosciences beaten expectations?

Inhibrx Biosciences has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Inhibrx Biosciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$2.51
Actual:
Q2 2026
Missed
Estimate:-$2.28
Actual:-$2.34
Difference:-$0.06
Q1 2026
Missed
Estimate:-$1.79
Actual:-$2.15
Difference:-$0.37
Price reaction (1 day):-6.5 %
Price reaction (7 days):-4.8 %
Q4 2025
Missed
Estimate:-$2.08
Actual:-$2.11
Difference:-$0.03
Price reaction (1 day):-6.1 %
Price reaction (7 days):+1.4 %
Q2 2025
Missed
Estimate:-$1.72
Actual:-$2.28
Difference:-$0.56
Q1 2025
Beat
Estimate:-$2.60
Actual:-$1.85
Difference:+$0.75

Earnings statistics

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-4.9%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Inhibrx Biosciences
Ticker Symbol
INBX
ISIN
US45720N1037
Country
🇺🇸
USA
Sector